Dr. Vishal Bansal on Life After Impact: The Concussion Recovery Podcast
In 2012, our co-founder Dr. Vishal Bansal was sitting in a corner office at UCSD, reading scientific literature on the gut-brain axis, when he found one paper showing that a hormone produced in the stomach helped injured neurons regenerate. He just sat down with Dr. Ayla Wolf on the Life After Impact podcast to tell the full story.
On why concussion has no drug treatment:
"For mild brain injury, we really have no treatment. We just basically tell patients you have to rest, you'll get better, take Motrin as needed, Tylenol as needed. Many of our patients have symptoms that last for months, sometimes even years."
On the discovery that started Oxeia:
"When you stimulated [brain cells] with a hormone called ghrelin, those neurons regenerated. And that was my aha moment."
Oxeia's Phase 2a trial at the University of Kansas Medical Center, published in Neurotrauma Reports, showed an 85% responder rate. To our knowledge, it is the first meaningful improvement in persistent concussion symptoms from any drug candidate. There has never been an FDA-approved drug treatment for concussion. We are working to build the first.
Episode courtesy of Life After Impact with Dr. Ayla Wolf.
Join the mission to bring the first FDA-approved treatment for persistent concussion symptoms to market.
Invest nowThis Reg CF offering is made available through StartEngine Primary LLC, member FINRA/SIPC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
